Plasma microRNA-21 is a potential diagnostic biomarker of acute myocardial infarction

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue 2, 2016, Pages 323-329

  Zhang, Y ^a   Liu, Y J ^a   Liu, T ^a   Zhang, H ^a   Yang, S J ^b  

^a TIANJIN CHEST HOSPITAL   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Ami; Diagnosis; Mir 21

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; MICRORNA 21; TROPONIN I; MICRORNA; MIRN21 MICRORNA, HUMAN;

ACUTE HEART INFARCTION; ADULT; ANGINA PECTORIS; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; ACUTE DISEASE; AGED; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; MYOCARDIAL INFARCTION;

ACUTE DISEASE; ADULT; AGED; ANGINA PECTORIS; BIOMARKERS; CASE-CONTROL STUDIES; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIAL INFARCTION; ROC CURVE; TROPONIN I;

EID: 84981501493     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. MORTALITY GBD, CAUSES OF DEATH C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117-171.
2. ALPERT JS, THYGESEN K, ANTMAN E, BASSAND JP. Myocardial infarction redefined-A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
3. BARTEL DP. MICRORNAS: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
4. AMBROS V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
5. DIMMELER S, NICOTERA P. MicroRNAs in age-related diseases. EMBO Mol Med 2013; 5: 180-190.
6. ABE M, BONINI NM. MicroRNAs and neurodegeneration: Role and impact. Trends Cell Biol 2013; 23: 30-36.
7. THUM T, CONDORELLI G. Long Noncoding RNAs and MicroRNAs in Cardiovascular Pathophysiology. Circ Res 2015; 16: 751-762.
8. SALA V, BERGERONE S, GATTI S, GALLO S, PONZETTO A, PONZETTO C, CREPALDI T. MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miRmedicine. Cell Mol Life Sci 2014; 71: 1439-1452.
9. YANG B, LIN H, XIAO J, LU Y, LUO X, LI B, ZHANG Y, XU C, BAI Y, WANG H, CHEN G, WANG Z. The muscle- specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007; 13: 486-491.
10. WANG JX, JIAO JQ, LI Q, LONG B, WANG K, LIU JP, LI YR, LI PF. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 2011; 17: 71-78.
11. TU Y, WAN L, FAN Y, WANG K, BU L, HUANG T, CHENG Z, SHEN B. Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway. PLoS One 2013; 8: E75872.
12. CHENG Y, ZHU P, YANG J, LIU X, DONG S, WANG X, CHUN B, ZHUANG J, ZHANG C. Ischaemic preconditioning- regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-Apoptosis through its target PDCD4. Cardiovasc Res 2010; 87: 431-439.
13. THUM T, GROSS C, FIEDLER J, FISCHER T, KISSLER S, BUSSEN M, GALUPPO P, JUST S, ROTTBAUER W, FRANTZ S, CASTOLDI M, SOUTSCHEK J, KOTELIANSKY V, ROSENWALD A, BASSON MA, LICHT JD, PENA JT, ROUHANIFARD SH, MUCKENTHALER MU, TUSCHL T, MARTIN GR, BAUERSACHS J, ENGELHARDT S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980-984.
14. DONG S, MA W, HAO B, HU F, YAN L, YAN X, WANG Y, CHEN Z, WANG Z. microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2. Int J Clin Exp Pathol 2014; 7: 565-574.
15. WATSON CJ, GUPTA SK, O'CONNELL E, THUM S, GLEZEVA N, FENDRICH J, GALLAGHER J, LEDWIDGE M, GROTELEVI L, MCDONALD K, THUM T. MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure. Eur J Heart Fail 2015; 17: 405-415.
16. WONG LL, ARMUGAM A, SEPRAMANIAM S, KAROLINA DS, LIM KY, LIM JY, CHONG JP, NG JY, CHEN YT, CHAN MM, CHEN Z, YEO PS, NG TP, LING LH, SIM D, LEONG KT, ONG HY, JAUFEERALLY F, WONG R, CHAI P, LOW AF, LAM CS, JEYASEELAN K, RICHARDS AM. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 2015; 17: 393-404.
17. AI J, ZHANG R, LI Y, PU J, LU Y, JIAO J, LI K, YU B, LI Z, WANG R, WANG L, LI Q, WANG N, SHAN H, LI Z, YANG B. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010; 391: 73-77.
18. LARSEN L, ROSENSTIERNE MW, GAARN LW, BAGGE A, PEDERSEN L, DAHMCKE CM, NIELSEN JH, DALGAARD LT. Expression and localization of microRNAs in perinatal rat pancreas: Role of miR-21 in regulation of cholesterol metabolism. PLoS One 2011; 6: E25997.
19. KIDA K, NAKAJIMA M, MOHRI T, ODA Y, TAKAGI S, FUKAMI T, YOKOI T. PPARalpha is regulated by miR-21 and miR-27b in human liver. Pharm Res 2011; 28: 2467-2476.
20. JAFFE AS, BABUIN L, APPLE FS. Biomarkers in acute cardiac disease: The present and the future. J Am Coll Cardiol 2006; 48: 1-11.
21. WANG RJ, ZHENG YH, WANG P, ZHANG JZ. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Int J Clin Exp Pathol 2015; 8: 765-771.
22. TOIYAMA Y, TANAKA K, INOUE Y, MOHRI Y, KUSUNOKI M. Circulating cell-free microRNAs as biomarkers for colorectal cancer. Surg Today 2016; 46: 13-24.
23. WANG Z, WEI M, REN Y, LIU H, WANG M, SHI K, JIANG H. miR149 rs71428439 polymorphism and risk of clear cell renal cell carcinoma: A case-control study. Tumour Biol 2014; 35: 12127-12130.
24. DUONG VAN HUYEN JP, TIBLE M, GAY A, GUILLEMAIN R, AUBERT O, VARNOUS S, ISERIN F, ROUVIER P, FRANCOIS A, VERNEREY D, LOYER X, LEPRINCE P, EMPANA JP, BRUNEVAL P, LOUPY A, JOUVEN X. MicroRNAs as non-invasive biomarkers of heart transplant rejection. Eur Heart J 2014; 35: 3194-3202.
25. PATRICK DM, MONTGOMERY RL, QI X, OBAD S, KAUPPINEN S, HILL JA, VAN ROOIJ E, OLSON EN. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 2010; 120: 3912-3916.
26. VAN ROOIJ E, SUTHERLAND LB, THATCHER JE, DIMAIO JM, NASEEM RH, MARSHALL WS, HILL JA, OLSON EN. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008; 105: 13027- 13032.
27. KUKREJA RC, YIN C, SALLOUM FN. MicroRNAs: new players in cardiac injury and protection. Mol Pharmacol 2011; 80: 558-564.
28. VILLAR AV, GARCIA R, MERINO D, LLANO M, COBO M, MONTALVO C, MARTIN-DURAN R, HURLE MA, NISTAL JF. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int J Cardiol 2013; 167: 2875-281.
29. XU F, XU L, WANG M, AN G, FENG G. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: A systematic review and metaanalysis. Colorectal Dis 2015; 17: O100-O107.
30. WU K, LI L, LI S. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: An updated meta-Analysis based on 36 studies. Tumour Biol 2014; 36: 1973-1981.
31. SHAN L, JI Q, CHENG G, XIA J, LIU D, WU C, ZHU B, DING Y. Diagnostic value of circulating miR-21 for colorectal cancer: A meta-Analysis. Cancer Biomark 2015; 15: 47-56.
32. BASATI G, EMAMI RAZAVI A, ABDI S, MIRZAEI A. Elevated level of microRNA-21 in the serum of patients with colorectal cancer. Med Oncol 2014; 31: 205.
33. ZHONG X, CHUNG AC, CHEN HY, DONG Y, MENG XM, LI R, YANG W, HOU FF, LAN HY. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 2013; 56: 663-674.
34. RUAN Q, WANG T, KAMESWARAN V, WEI Q, JOHNSON DS, MATSCHINSKY F, SHI W, CHEN YH. The microRNA- 21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci U S A 2011; 108: 12030-12035.
35. YANG S, BANERJEE S, FREITAS A, CUI H, XIE N, ABRAHAM E, LIU G. miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 2012; 302: L521- L529.